- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01807533
A Family-Centered Intervention Program for Preterm Infants: Effects and Their Biosocial Pathways
22 augustus 2018 bijgewerkt door: National Taiwan University Hospital
Four hypotheses will be tested in this study:
- The intervention group performs better in child, parent and transactions outcomes than the control group throughout the follow-up period.
- The intervention group shows greater changes in early neurophysiological brain functions and transactions within the family that lead to better neurodevelopmental outcomes than the control group.
- Certain polymorphisms of the dopamine-related genes are associated with the neurodevelopmental outcomes in VLBW preterm infants.
- Very low birth weight preterm infants carrying more genetic plasticity in the dopamine-related genes may benefit more from the interventions than those carrying less genetic plasticity.
Studie Overzicht
Toestand
Voltooid
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
A total of 275 VLBW preterm infants (269 participants and 6 pilots) were recruited at three medical centers in northern and southern Taiwan and were randomly assigned to the FCIP or UCP group.
Outcome assessments included primary (neurobehavioral development) and secondary measures (neurophysiological performance, parents' stress and transactions within the family).
The neurophysiological and transactions data were examined for whether they mediate intervention effects on child development.
In addition, these infants 219 VLBW preterm infants and 118 term infants in our prior intervention studies were collected buccal cells for assessment of the polymorphisms of dopamine-related genes, which are involved in the neurotransmission of cognitive, sensorimotor and behavioral-emotional systems and postulated to be associated with several developmental and psychiatric illnesses.
The polymorphisms of dopamine-related genes were examined for potential moderating influence on the effects of the intervention for child development.
Studietype
Ingrijpend
Inschrijving (Werkelijk)
275
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
-
Tainan, Taiwan, 704
- National Cheng Kung University Hospital
-
Taipei, Taiwan, 100
- National Taiwan University Hospital
-
Taipei, Taiwan, 104
- MacKay Memorial Hospital
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Niet ouder dan 8 maanden (Kind)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- birth body weight < 1500 grams
- gestational age < 37 weeks
- parents of Taiwan nationality, married or together at delivery, and northern family residing in greater Taipei and southern family residing in greater Tainan, Kaohsiung, or Chiayi
Exclusion Criteria:
- severe neonatal and perinatal diseases (e.g., seizures, hydrocephalus, meningitis, grade III-IV IVH and grade II NEC)
- congenital or chromosome abnormality
- mother < 18 years, with mental retardation or history of maternal substance abuse at any time (smoking, alcohol, and drug)
Terminated Criteria:
- diagnosis of brain injury (e.g., PVL, stage IV ROP or greater)
- severe cardiopulmonary disease requiring invasive or non-invasive ventilator use at hospital discharge
- hospital discharge beyond 44 weeks' post-menstrual age.
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Family-centered intervention program
FCIP: family members were encouraged to present in all intervention sessions included 5 in-hospital intervention, 7 after-discharge interventions (0, 1, 2, 4, 6, 9, and 12 months of corrected age), and neonatal follow-up at 0, 1, 6, 12, 18, and 24 months of corrected age.
|
This program was in-hospital intervention, after-discharge intervention, and neonatal follow-up.
Five sessions of in-hospital intervention emphasized in the parental involvements with modulation of the NICU, a teaching of child developmental skills, feeding support, massage, interactional activities, child developmental skills, parent support and education, and transition home preparation.
The 7-session after-discharge intervention consisted of 4 clinic visits and 3 home visits with specific care in modulation of home environment, teaching of child developmental skills, feeding support, teaching of interactional activities, and parent support and education
Andere namen:
|
|
Ander: Usual care intervention program
UCP: family members were invited to present at least one session of the 5 in-hospital intervention session.
Parents and infants in the UCP group received 7 after-discharge phone calls (0, 1, 2, 4, 6, 9, and 12 months of corrected age) and neonatal follow-up at 0, 1, 6, 12, 18, and 24 months of corrected age.
|
This program was in-hospital intervention, after-discharge consultation, and neonatal follow-up.
Five sessions of in-hospital intervention emphasized in the parental involvements with modulation of the NICU, a teaching of child developmental skills, feeding support, massage, interactional activities, child developmental skills, parent support and education, and transition home preparation.
The after-discharge service was provided 7-phone calls for the general health consultation.
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Child: neurodevelopment functions (cognition, language and motor)
Tijdsspanne: 24 months of corrected age
|
Bayley Scales of Infant and Toddler Development - 2nd and 3rd edition
|
24 months of corrected age
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change of neurodevelopment functions (motor) from baseline
Tijdsspanne: 0 months of corrected age
|
The Neonatal Neurobehavioral Examination-Chinese Version (NNE-C) 2. World Health Organization Quality of Life- Brief Taiwan version
|
0 months of corrected age
|
|
Child: neurodevelopment functions (behavior)
Tijdsspanne: 24 months of corrected age
|
Child behavior checklist version 1.5-5 Y 2. World Health Organization Quality of Life- Brief Taiwan version
|
24 months of corrected age
|
|
Change of neurodevelopment functions (cognition, language and motor) from baseline
Tijdsspanne: 6,12, and 24 months
|
Bayley Scales of Infant and Toddler Development - 3rd edition 2. World Health Organization Quality of Life- Brief Taiwan version
|
6,12, and 24 months
|
|
Parental functions and change from baseline (pressure)
Tijdsspanne: 0, 6, 12, 18, and 24 months of corrected age
|
Parenting Stress Index 2. World Health Organization Quality of Life- Brief Taiwan version
|
0, 6, 12, 18, and 24 months of corrected age
|
|
Parental functions and change from baseline (Quality of Life)
Tijdsspanne: 0, 6, 12, 18, and 24 months of corrected age
|
World Health Organization Quality of Life- Brief Taiwan version
|
0, 6, 12, 18, and 24 months of corrected age
|
|
Transactional functions and change from baseline
Tijdsspanne: 6, 12, and 18 months of corrected age
|
Mother-infant interaction in free play at 6, 12, and 18 months of corrected age
|
6, 12, and 18 months of corrected age
|
|
Transactional functions and change from baseline
Tijdsspanne: 6 and 12 months of corrected age
|
Wakeful Position Questionnaire at 6 and 12 months of corrected age
|
6 and 12 months of corrected age
|
|
Transactions function: affordance
Tijdsspanne: 18 months of corrected age
|
1. Affordances in the Home Environment Motor Development- Chinese version
|
18 months of corrected age
|
|
Child: Medical data
Tijdsspanne: Birth to 24 months of corrected age
|
Chart review
|
Birth to 24 months of corrected age
|
|
Child: growth data and change from baseline
Tijdsspanne: 0, 1, 4, 6, 12, 18, and 24 months of corrected age
|
Chart review and measurement
|
0, 1, 4, 6, 12, 18, and 24 months of corrected age
|
|
Child: neurophysiological functions and change from baseline
Tijdsspanne: 1 and 4 months of corrected age
|
Electroencephalogram/event-related potential
|
1 and 4 months of corrected age
|
|
Child: genotyping and gene expression
Tijdsspanne: 0 month of corrected age
|
Buccal cell collection
|
0 month of corrected age
|
|
Parental adherence to Intervention
Tijdsspanne: 32-36 weeks (5 sessions), 0, 1, 2, 4, 6, 9, and 12 months
|
Only assessed in FCIP group
|
32-36 weeks (5 sessions), 0, 1, 2, 4, 6, 9, and 12 months
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Medewerkers
Publicaties en nuttige links
De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.
Algemene publicaties
- Li SJ, Tsao PN, Tu YK, Hsieh WS, Yao NJ, Wu YT, Jeng SF. Cognitive and motor development in preterm children from 6 to 36 months of age: Trajectories, risk factors and predictability. Early Hum Dev. 2022 Sep;172:105634. doi: 10.1016/j.earlhumdev.2022.105634. Epub 2022 Jul 28.
- Yu YT, Huang WC, Hsieh WS, Chang JH, Lin CH, Hsieh S, Lu L, Yao NJ, Fan PC, Lee CL, Tu YK, Jeng SF. Family-Centered Care Enhanced Neonatal Neurophysiological Function in Preterm Infants: Randomized Controlled Trial. Phys Ther. 2019 Dec 16;99(12):1690-1702. doi: 10.1093/ptj/pzz120.
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
22 mei 2012
Primaire voltooiing (Werkelijk)
10 januari 2017
Studie voltooiing (Werkelijk)
10 januari 2017
Studieregistratiedata
Eerst ingediend
29 januari 2013
Eerst ingediend dat voldeed aan de QC-criteria
6 maart 2013
Eerst geplaatst (Schatting)
8 maart 2013
Updates van studierecords
Laatste update geplaatst (Werkelijk)
24 augustus 2018
Laatste update ingediend die voldeed aan QC-criteria
22 augustus 2018
Laatst geverifieerd
1 maart 2017
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 201103075RB
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
NEE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .